SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-19-000519
Filing Date
2019-06-21
Accepted
2019-06-21 17:04:31
Documents
2
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3896
2 POWER OF ATTORNEY FOR GINKGO BIOWORKS, INC. poa_ginkgobioworks-061919.htm EX-24 5019
  Complete submission text file 0000904454-19-000519.txt   10562
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Issuer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210 877-422-5362
Ginkgo Bioworks, Inc. (Reporting) CIK: 0001648827 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37566 | Film No.: 19912285